<DOC>
	<DOCNO>NCT01954186</DOCNO>
	<brief_summary>To compare efficacy route timing oxytocin administration Active management third stage labour ( AMTSL ) .</brief_summary>
	<brief_title>When How Administer Oxytocin Active Management Third Stage Labour</brief_title>
	<detailed_description>Our objective determine efficient route timing oxytocin administration measure duration third stage labour , quantitative blood first hour delivery compare haemoglobin haematocrit change need additional intervention patient either spontaneous labour receive labour augmentation oxytocin .</detailed_description>
	<mesh_term>Postpartum Hemorrhage</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<criteria>singleton pregnancy 37th gestational week normal live vaginal delivery cephalic presentation active labor Fetal demise multiple pregnancy know coagulation disorder presentation anomaly placental pathology liver disease thrombocytopenia hypertension currently anticoagulants cesarean section , operative delivery deep vaginal tear chorioamnionitis develop HELLP syndrome ( hemolysis , elevate liver enzyme , low platelet count ) DIC ( disseminate intravascular coagulation ) delivery</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Oxytocin</keyword>
	<keyword>Active Management Third Stage Labour</keyword>
</DOC>